Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F1SI
|
|||
| Former ID |
DNC010264
|
|||
| Drug Name |
4-(2-(thiophen-3-yl)-9H-purin-6-yl)morpholine
|
|||
| Synonyms |
CHEMBL608095; 4-(2-(thiophen-3-yl)-9H-purin-6-yl)morpholine; SCHEMBL4438208
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H13N5OS
|
|||
| Canonical SMILES |
C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CSC=C4
|
|||
| InChI |
1S/C13H13N5OS/c1-6-20-7-9(1)11-16-12-10(14-8-15-12)13(17-11)18-2-4-19-5-3-18/h1,6-8H,2-5H2,(H,14,15,16,17)
|
|||
| InChIKey |
SQTGJTBXJLFTBF-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Novel purine and pyrazolo[3,4-d]pyrimidine inhibitors of PI3 kinase-alpha: Hit to lead studies. Bioorg Med Chem Lett. 2010 Jan 15;20(2):636-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.